Status:
RECRUITING
A Clinico-biological Database of Lung Cancers
Lead Sponsor:
University Hospital, Lille
Collaborating Sponsors:
Institut Pasteur de Lille
University of Lille Nord de France
Conditions:
Lung Cancer
Eligibility:
All Genders
Brief Summary
This prospective, single-center, interventional study is conducted in order to achieve a biological bank accompanied by clinical data. Blood samples, optional tumor tissue and fecal samples are collec...
Eligibility Criteria
Inclusion
- Documented new diagnosis of lung cancer by histology or cytology, or lung tumor leading to lung cancer suspicion without diagnosis for which an antineoplastic treatment is indicated
- Indication of a treatment by surgery, chemotherapy, radio-chemotherapy, radiotherapy or targeted therapy as first line of lung cancer treatment
- ability of the subject to follow study procedures
- Age \> 18 years
- Subject must have at least one measurable and/or assessable lesion in regard with RECIST 1.1 criteria
- Subject is registered with a social security scheme
- Subject is taken in charge at Pneumology department of Lille UH
- Subject has signed an informed consent form
Exclusion
- Patient with a history of treatment by antineoplastic chemotherapy, radio-chemotherapy, radiotherapy or targeted therapy, or presenting a contra indication to antineoplastic treatment administration
- Subject is not willing to sign the informed consent form
- Subject is not registered with a social security scheme
- Subject is not francophone
- Subject is deprived of his/her liberty or under trusteeship
Key Trial Info
Start Date :
March 13 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2032
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT03387865
Start Date
March 13 2019
End Date
March 1 2032
Last Update
October 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Calmette, CHU
Lille, France